EU poised to secure Sanofi deal for coronavirus vaccine

By Foo Yun Chee BRUSSELS (Reuters) - The European Union's executive on Friday wrapped up preliminary talks with French drugmaker Sanofi aimed at securing its COVID-19 vaccine for the 27-country EU bloc, the latest deal with vaccine producers. Armed with an emergency fund of more than 2 billion euros ($2.4 billion), the European Commission wants to strike deals with up to six drugmakers for their vaccines for their 450 million citizens against the coronavirus that has killed 674,000 people worldwide

Reuters August 01, 2020 00:06:40 IST
EU poised to secure Sanofi deal for coronavirus vaccine

EU poised to secure Sanofi deal for coronavirus vaccine

By Foo Yun Chee

BRUSSELS (Reuters) - The European Union's executive on Friday wrapped up preliminary talks with French drugmaker Sanofi aimed at securing its COVID-19 vaccine for the 27-country EU bloc, the latest deal with vaccine producers.

Armed with an emergency fund of more than 2 billion euros ($2.4 billion), the European Commission wants to strike deals with up to six drugmakers for their vaccines for their 450 million citizens against the coronavirus that has killed 674,000 people worldwide.

The Commission said the aim of the talks with Sanofi was to clinch an advance purchase deal.

"The envisaged contract with Sanofi would provide for an option for all EU Member States to purchase the vaccine," the Commission said in a statement.

"It is envisaged that, once a vaccine has proven to be safe and effective against COVID-19, the Commission would have a contractual framework in place for the purchase of 300 million doses, on behalf of all EU member states."

A Commission spokesman said he could not comment on when a deal would be announced and the possible price for the vaccine, calling it a quite promising step towards an eventual agreement.

Sanofi, which is working on two vaccine projects including one in partnership with GlaxoSmithKline , was not immediately available for comment. The British drugmaker declined to comment.

Earlier this week, EU talks with Sanofi, Pfizer and Johnson & Johnson hit an impasse over price, payment method and potential liability costs, EU officials told Reuters.

Other pharmaceutical companies talking to the EU include France's Valneva , Moderna and biotech firms BioNTech and Germany's CureVac.

(Reporting by Foo Yun Chee, additional reporting by Francesco Guarascio in Brussels and Ludwig Burger in Frankfurt; Editing by Andrew Cawthorne and Jane Merriman)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. crude output in May plummets by a record 2 million bpd
Business

U.S. crude output in May plummets by a record 2 million bpd

By Jessica Resnick-Ault and Scott DiSavino NEW YORK (Reuters) - U.S. crude oil production plummeted in May, falling a record 2 million barrels per day to 10 million bpd, the U.S. Energy Information Administration said in a monthly report Friday.

U.S. consumer spending presses ahead; declining income poses challenge
Business

U.S. consumer spending presses ahead; declining income poses challenge

By Lucia Mutikani WASHINGTON (Reuters) - U.S. consumer spending increased for a second straight month in June, setting up consumption for a rebound in the third quarter, though the recovery could be limited by a resurgence in COVID-19 cases and the end of expanded unemployment benefits.

U.S. imposes sanctions on Chinese company over abuse of Uighurs
Business

U.S. imposes sanctions on Chinese company over abuse of Uighurs

By Steve Holland and Daphne Psaledakis WASHINGTON (Reuters) - The United States intensified its economic pressure on China's Xinjiang province on Friday, imposing sanctions on a powerful Chinese company and two officials for what it said were human rights abuses against Uighurs and other ethnic minorities. The move, the latest blow to U.S.-China relations, came a week after U.S